Advanced Human Imaging Ltd ADR (AHI)

NASDAQ

Currency in USD

1.500

0.000(0.00%)

Closed31/01

Fair Value

Day's Range

1.445

1.540

52 wk Range

1.410

2.559

AHI Income Statement

Explore the detailed Advanced Human Imaging Ltd ADR income statement, offering a comprehensive view of the company’s financial performance. Review essential metrics such as revenue, gross profit, operating income, and net income over selected periods. This page provides a clear breakdown of profitability and operational efficiency, helping you evaluate Advanced Human Imaging Ltd ADR's growth trends and overall financial health.

Advanced Income Statement

Period Ending:

2015

30/06

2016

30/06

2017

30/06

2018

30/06

2019

30/06

2020

30/06

2021

30/06

2022

30/06

2023

30/06

2024

30/06

Total Revenues

0.25

0.61

0.27

0.65

2.68

Total Revenues Growth

+60.7%

+148.29%

-55.69%

+141.63%

+309.5%

Cost Of Revenues

3.9

9.89

11.76

6.43

6.41

Gross Profit

-3.65

-9.27

-11.49

-5.77

-3.72

Gross Profit Growth

+0.48%

-153.88%

-23.9%

+49.77%

+35.47%

Gross Profit Margin %

-1,482.92%

-1,516.31%

-4,240.21%

-881.42%

-138.9%

Other Operating Expenses, Total

2.69

3.1

7.36

4.59

5.34

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+47.08%	+15.48%	+137.26%	-37.68%	+16.32%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2.69	3.14	7.89	6.41	4.98
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-0.04	-0.89	-2.14	-

Operating Income

-6.34

-12.38

-18.85

-10.36

-9.06

Operating Income Growth

-15.33%

-95.23%

-52.32%

+45.05%

+12.53%

EBIT Margin %

-2,573.64%

-2,023.6%

-6,956.65%

-1,582.06%

-337.91%

Net Interest Expenses

-0.14

-0.21

-0.01

-0.22

-0.46

Net Interest Expenses Growth

-5.17%

-45.25%

+95.89%

-2,506.35%

-106.53%

Interest Expense, Total

-0.14

-0.25

-0.16

-0.48

-0.69

Interest And Investment Income

0

0.04

0.16

0.25

0.23

Other Non Operating Expenses, Total

0.42

0.55

0.31

0.04

-

EBT, Excl. Unusual Items

-6.06

-12.03

-18.55

-10.54

-9.52

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-

-

-

-

-

EBT, Incl. Unusual Items

-6.06

-14.85

-20.08

-12.83

-4.15

EBT, Incl. Unusual Items Growth

-24.01%

-144.86%

-35.24%

+36.11%

+67.67%

EBT, Incl. Unusual Items Margin

-2,461.08%

-2,427.1%

-7,408.21%

-1,958.83%

-154.66%

Income Tax Expense

-0.67

-0.78

-

-

-

Net Income to Company

-5.4

-14.06

-20.08

-12.83

-4.15

Minority Interest

-

-

-

-

-

Net Income

-5.4

-14.06

-20.08

-12.83

-4.15

Net Income Growth

-23.85%

-160.56%

-42.78%

+36.11%

+67.67%

Net Income Margin %

-2,190.64%

-2,298.85%

-7,408.21%

-1,958.83%

-154.66%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

-5.4

-14.06

-20.08

-12.83

-4.15

Basic EPS - Continuing Operations

-0.05

-0.11

-0.13

-0.07

-0.02

Basic EPS - Continuing Operations Growth

+0.02%

-117.2%

-16.75%

+46.95%

+76.55%

Diluted EPS - Continuing Operations

-0.05

-0.11

-0.13

-0.07

-0.02

Diluted EPS - Continuing Operations Growth

+0%

-117.13%

-16.75%

+46.94%

+76.55%

Basic Weighted Average Shares Outstanding

104.62

125.5

153.49

184.84

254.8

Diluted Weighted Average Shares Outstanding

104.62

125.5

153.49

184.84

254.8

Dividend Per Share

-

-

-

-

-

Dividend Per Share Growth

-

-

-

-

-

EBITDA

-6.3

-12.33

-18.56

-10.29

-8.7

EBITDA Growth

-15.21%

-95.74%

-50.47%

+44.58%

+15.39%

EBITDA Margin %

-2,557.92%